Jane Street Group, LLC Calliditas Therapeutics Ab Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$14.12 - $22.49 $12,510 - $19,926	886 Added 7.63%	12,491 $191,000
Q2 2022 Aug 16, 2022	BUY	$12.85 - $20.36 $796 - $1,262	62 Added 0.54%	11,605 $210,000
Q1 2022 May 17, 2022	BUY	$15.14 - $25.55 $174,761 - $294,923	11,543 New	11,543 $221,000
Q3 2021 Nov 16, 2021	SELL	$21.03 - $33.19 $151,752 - $239,499	-7,216 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.02 - $31.17 $187,760 - $224,922	7,216 New	7,216 $211,000
Q1 2021 May 18, 2021	SELL	$27.01 - $32.92 $204,114 - $248,776	-7,557 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$23.34 - $36.65 $63,508 - $99,724	-2,721 Reduced 26.47%	7,557 $256,000
Q3 2020 Nov 17, 2020	BUY	$21.61 - $25.69 $26,861 - $31,932	1,243 Added 13.76%	10,278 $244,000
Q2 2020 Aug 17, 2020	BUY	$19.17 - $23.2 $173,200 - $209,612	9,035 New	9,035 $219,000

1.84K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.